Tech Company M&A Transactions
Abgenix Acquisition
Operating out of Fremont, Abgenix was bought by Amgen. Amgen said the transaction price was $2.2 billion.
Transaction Overview
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6701 Kaiser Drive
Fremont, CA 94555
USA
Fremont, CA 94555
USA
Phone
Website
Email Address
Not Recorded
Overview
Abgenix, Inc. is a biopharmaceutical company that is focused on the discovery, development and manufacture of human therapeutic antibodies for the treatment of a variety of diseases. The Company is co-developing its advanced product candidate, panitumumab, with Immunex Corporation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Greer Scott
Browse more venture capital transactions:
Prev: 12/14/2005: Harris Stratex Networks venture capital transaction
Next: 12/14/2005: Celerus Diagnostics venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs